Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 06-2016 | 06-2015 | 06-2014 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,400 | 117,200 | 80,200 | 176,200 | 147,200 |
| Depreciation Amortization | 48,300 | 26,800 | 25,000 | 13,800 | 8,900 |
| Income taxes - deferred | 800 | 13,200 | -400 | 8,100 | 7,400 |
| Accounts receivable | 500 | -25,900 | -34,400 | -24,400 | -67,200 |
| Accounts payable and accrued liabilities | -3,000 | 0 | -3,100 | -1,500 | 8,000 |
| Other Working Capital | 5,600 | -52,500 | -40,700 | -60,000 | -40,900 |
| Other Operating Activity | 36,600 | 87,500 | 113,900 | 78,000 | 110,500 |
| Operating Cash Flow | $106,200 | $166,300 | $140,500 | $190,200 | $173,900 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -5,000 |
| PPE Investments | -6,100 | -5,000 | -23,900 | -14,300 | -11,400 |
| Net Acquisitions | -216,100 | -37,000 | -20,100 | -223,500 | N/A |
| Purchase Of Investment | -87,500 | -164,500 | -80,700 | -161,800 | -443,800 |
| Sale Of Investment | 163,400 | 115,100 | 165,600 | 382,500 | 385,300 |
| Investing Cash Flow | $-146,300 | $-91,400 | $40,900 | $-17,100 | $-74,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 199,000 | 0 | 0 | N/A | N/A |
| Debt Issued | 204,000 | 0 | 0 | N/A | N/A |
| Debt Repayment | -105,000 | 0 | 0 | N/A | N/A |
| Common Stock Issued | 6,000 | 94,300 | 30,000 | 64,800 | 57,800 |
| Common Stock Repurchased | -31,600 | -162,600 | -210,700 | -287,700 | -146,300 |
| Other Financing Activity | -200,600 | 0 | 3,400 | 11,100 | 7,900 |
| Financing Cash Flow | $71,800 | $-68,300 | $-177,300 | $-211,800 | $-80,600 |
| Exchange Rate Effect | 2,200 | -2,200 | -4,800 | -600 | -700 |
| Beginning Cash Position | 68,500 | 64,100 | 64,800 | 104,100 | 86,400 |
| End Cash Position | 102,400 | 68,500 | 64,100 | 64,800 | 104,100 |
| Net Cash Flow | $33,900 | $4,400 | $-700 | $-39,300 | $17,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 106,200 | 166,300 | 140,500 | 190,200 | 173,900 |
| Capital Expenditure | -6,100 | -5,000 | -23,900 | -14,300 | -11,400 |
| Free Cash Flow | 100,100 | 161,300 | 116,600 | 175,900 | 162,500 |